Skip to search formSkip to main contentSkip to account menu

amixicile

Known as: VPC162134 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzamidesThiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have In Vitro Activity against Cryptosporidium
Cryptosporidium species cause significant morbidity in malnourished children. Nitazoxanide (NTZ) is the only approved treatment… 
Review
2017
Review
2017
Amixicile Inhibits Anaerobic Bacteria within an Oral Microbiome Derived from Patients with Chronic Periodontitis
AMIXICILE INHIBITIS ANAEROBIC BACTERIA WITHIN AN ORAL MICROBIOME DERIVED FROM PATIENTS WITH CHRONIC PERIODONTITIS By Kane W… 
2017
2017
Come Fly with Me: Using Amixicile to Target Periodontal Pathogens and Elucidating the Innate Immune Response in Drosophila melanogaster
2016
2016
The Effects of Amixicile, A Pyruvate Ferredoxin Oxidoreductase Inhibitor, on Oral Treponemes
2014
2014
Shows Efficacy against Helicobacter pylori Clostridium difficile Infections That Also Therapeutic Developed for Treatment of Preclinical Studies of Amixicile , a Systemic
Published Ahead of Print 2 June 2014. 10.1128/AAC.03112-14. 2014, 58(8):4703. DOI: Antimicrob. Agents Chemother. Guerrant and… 
2014
2014
Preclinical Studies of Amixicile : A Systemic Therapeutic Developed 1 for Treatment of Clostridium difficile Infections also shows Efficacy 2 against Helicobacter pylori 3 4 5 6
Review
2013
Review
2013
New developments in chemotherapeutic options for Clostridium difficile colitis
Purpose of review Clostridium difficile infections (CDIs) are of increasing concern in healthcare due to increasing incidence as… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)